Cargando…
Precise activity measurements of medical radionuclides using an ionization chamber: a case study with Terbium-161
BACKGROUND: (161)Tb draws an increasing interest in nuclear medicine for therapeutic applications. More than 99% of the emitted gamma and X-rays of (161)Tb have an energy below 100 keV. Consequently, precise activity measurement of (161)Tb becomes inaccurate with radionuclide dose calibrators when u...
Autores principales: | Juget, Frédéric, Talip, Zeynep, Nedjadi, Youcef, Durán, M. Teresa, Grundler, Pascal V., Zeevaart, Jan Rijn, van der Meulen, Nicholas P., Bailat, Claude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921384/ https://www.ncbi.nlm.nih.gov/pubmed/35286498 http://dx.doi.org/10.1186/s40658-022-00448-0 |
Ejemplares similares
-
Terbium-161 for PSMA-targeted radionuclide therapy of
prostate cancer
por: Müller, Cristina, et al.
Publicado: (2019) -
Activity Measurement of (44)Sc and Calibration of Activity Measurement Instruments on Production Sites and Clinics
por: Juget, Frederic, et al.
Publicado: (2023) -
Production and characterization of no-carrier-added (161)Tb as an alternative to the clinically-applied (177)Lu for radionuclide therapy
por: Gracheva, Nadezda, et al.
Publicado: (2019) -
Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms
por: Borgna, Francesca, et al.
Publicado: (2021) -
Ytterbium-175 half-life determination
por: Durán, M Teresa, et al.
Publicado: (2021)